Redmile Group’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $19.1M | Sell |
1,276,676
-31,387
| -2% | -$469K | 2.03% | 15 |
|
2025
Q1 | $15.3M | Sell |
1,308,063
-11,700
| -0.9% | -$137K | 1.45% | 19 |
|
2024
Q4 | $30.2M | Buy |
1,319,763
+355,416
| +37% | +$8.12M | 2.1% | 18 |
|
2024
Q3 | $40.5M | Sell |
964,347
-49,316
| -5% | -$2.07M | 2.38% | 17 |
|
2024
Q2 | $36.9M | Buy |
1,013,663
+78,411
| +8% | +$2.85M | 2.23% | 19 |
|
2024
Q1 | $47.6M | Sell |
935,252
-11,645
| -1% | -$593K | 1.75% | 19 |
|
2023
Q4 | $18.4M | Buy |
946,897
+801,286
| +550% | +$15.5M | 0.66% | 40 |
|
2023
Q3 | $2.3M | Hold |
145,611
| – | – | 0.11% | 58 |
|
2023
Q2 | $2.42M | Buy |
145,611
+53,231
| +58% | +$884K | 0.09% | 66 |
|
2023
Q1 | $1.29M | Sell |
92,380
-148
| -0.2% | -$2.07K | 0.06% | 70 |
|
2022
Q4 | $942K | Sell |
92,528
-79,319
| -46% | -$807K | 0.04% | 66 |
|
2022
Q3 | $2.2M | Hold |
171,847
| – | – | 0.09% | 63 |
|
2022
Q2 | $3.54M | Sell |
171,847
-1,425
| -0.8% | -$29.4K | 0.14% | 62 |
|
2022
Q1 | $6.52M | Sell |
173,272
-1,270
| -0.7% | -$47.8K | 0.2% | 57 |
|
2021
Q4 | $16.8M | Sell |
174,542
-820
| -0.5% | -$79K | 0.38% | 48 |
|
2021
Q3 | $25.4M | Sell |
175,362
-20,600
| -11% | -$2.98M | 0.44% | 49 |
|
2021
Q2 | $36.2M | Sell |
195,962
-9,916
| -5% | -$1.83M | 0.54% | 49 |
|
2021
Q1 | $50.7M | Sell |
205,878
-715
| -0.3% | -$176K | 0.71% | 42 |
|
2020
Q4 | $58.3M | Sell |
206,593
-2,041
| -1% | -$576K | 0.71% | 43 |
|
2020
Q3 | $50.1M | Buy |
208,634
+6,573
| +3% | +$1.58M | 0.92% | 38 |
|
2020
Q2 | $67.1M | Hold |
202,061
| – | – | 1.24% | 24 |
|
2020
Q1 | $46M | Buy |
202,061
+106,019
| +110% | +$24.1M | 1.29% | 27 |
|
2019
Q4 | $23.7M | Buy |
+96,042
| New | +$23.7M | 0.57% | 46 |
|
2015
Q4 | – | Sell |
-25,715
| Closed | -$7.24M | – | 62 |
|
2015
Q3 | $7.24M | Buy |
+25,715
| New | +$7.24M | 0.55% | 37 |
|